This website uses cookies to improve your experience. By clicking “Accept” you are agreeing to our Privacy Policy.
Bladder cancer originates in the tissues of the urinary bladder. It usually occurs in older adults, with nearly 9 in 10 individuals diagnosed with this cancer aged above 55 years. It is estimated that the likelihood of men developing bladder cancer in their lifetime is around 1 in 28 whereas in women, the chance is roughly 1 in 89. The increasing prevalence of bladder cancer and the growing elderly population are anticipated to aid the market growth. The rising advancements in diagnostic techniques and the introduction of targeted therapies and immunotherapies are projected to elevate the market value. Moreover, the growth in clinical trials and the rising preference for combination therapies are likely to impact the market dynamics.
According to the American Cancer Society, nearly 83,190 new cases of bladder cancer, comprising 63,070 men and 20,120 women, are projected to occur in the United States in 2024. Further, it is estimated that bladder cancer will be responsible for 16,840 deaths in the country, indicating the need for effective treatments that can address the unmet needs in oncology. Thus, the increasing burden of bladder cancer owing to factors such as the growing aging population and the rising exposure to carcinogens are contributing to the market demand.
Based on the cancer type, the market segmentation includes transitional cell carcinoma, invasive bladder cancer, superficial bladder cancer, adenocarcinoma, and others. Transitional cell carcinoma or urothelial carcinoma is one of the most common types of bladder cancer, comprising more than 90% of the cases in industrialized countries. The growing demand for innovative treatments such as checkpoint inhibitors and the rising focus on combination therapies are expected to bolster the growth of this segment.
The market report also offers insights based on treatment type, end user, and region.
The market report offers insight into various geographical locations, including the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States dominates the market share which can be attributed to its substantial burden of bladder cancer and the high demand for advanced treatments. The presence of an advanced healthcare system and key market players in the country also support the market growth. The easy availability of immunotherapies and targeted therapies, such as checkpoint inhibitors, is likely to boost market demand in the region. Moreover, significant investment in clinical trials and robust regulatory support from the FDA are anticipated to aid market expansion.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124